In vivo self-assembled small RNAs as a new generation of RNAi therapeutics
2021 · Cell Research · 119 citations
https://doi.org/10.1038/s41422-021-00491-z
X
Xinyan Zhou
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
44
Papers
679
Citations
11
h-index
11
i10-index
Xinyan Zhou is an academic researcher from Zhejiang A & F University. The author has contributed to research in topics: MicroRNA in disease regulation & RNA modifications and cancer & Congenital heart defects research. The author has an h-index of 11, co-authored 38 publications.
ORCID: 0000-0002-3887-8121Papers by this author
worksmiR-338-3p functions as a tumor suppressor in gastric cancer by targeting PTP1B
2018 · Cell Death and Disease · 91 citations
https://doi.org/10.1038/s41419-018-0611-0
<scp>PTP</scp>1B markedly promotes breast cancer progression and is regulated by miR‐193a‐3p
2018 · FEBS Journal · 74 citations
https://doi.org/10.1111/febs.14724
In vivo self-assembled siRNA as a modality for combination therapy of ulcerative colitis
2022 · Nature Communications · 33 citations
https://doi.org/10.1038/s41467-022-33436-0
Essential role of MESP1-RING1A complex in cardiac differentiation
2022 · Developmental Cell · 7 citations
https://doi.org/10.1016/j.devcel.2022.10.009
Therapeutic application of chick early amniotic fluid: effective rescue of acute myocardial ischemic injury by intravenous administration
2022 · Cell Regeneration · 4 citations
https://doi.org/10.1186/s13619-022-00110-1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat